HomeACTU • NASDAQ
add
Actuate Therapeutics Inc
Previous close
$9.76
Day range
$9.79 - $10.70
Year range
$5.52 - $11.73
Market cap
206.06M USD
Avg Volume
60.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.37M | -18.11% |
Net income | -6.32M | 23.86% |
Net profit margin | — | — |
Earnings per share | -0.32 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.89M | 88.05% |
Total assets | 4.48M | 66.13% |
Total liabilities | 9.57M | -37.34% |
Total equity | -5.09M | — |
Shares outstanding | 19.62M | — |
Price to book | -37.54 | — |
Return on assets | -230.61% | — |
Return on capital | 638.66% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -6.32M | 23.86% |
Cash from operations | -4.62M | 11.98% |
Cash from investing | — | — |
Cash from financing | -133.48K | -103.06% |
Net change in cash | -4.75M | -433.75% |
Free cash flow | -3.42M | — |
About
Founded
2015
Headquarters
Website
Employees
10
